Even if each tumour is composed of a mixture of heterogeneous tumour cells, the released EpCAM+ and EpCAM+CD147+ taMPs can be reliable detected in the circulation in both primary and metastatic tumour-bearing patients (Figure 4E). Here, EPCAM is linked to metastatic neoplasm.